EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink

Cornelius J Fernandez, Mohammed Alkhalifah iD, Hafsa Afsar, Joseph M Pappachan iD

Pathogens · 10.01.2024 · 13 (1) · 68

DOI: 10.3390/pathogens13010068 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 10.01.2024. Verfasst von Cornelius J Fernandez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Pilgrim Hospital, United Lincolnshire Hospitals NHS Trust, Boston PE21 9QS, UK. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis C, Chronic. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated fatty liver disease (MAFLD) has now affected nearly one-third of the global population and has become the number one cause of chronic liver disease in the world because of the obesity pandemic. Chronic hepatitis resulting from hepatitis B virus (HBV) and hepatitis C virus (HCV) remain significant challenges to liver health even in the 21st century. The co-existence of MAFLD and chronic viral hepatitis can markedly alter the disease course of individual diseases and can complicate the management of each of these disorders. A thorough understanding of the pathobiological interactions between MAFLD and these two chronic viral infections is crucial for appropriately managing these patients. In this comprehensive clinical review, we discuss the various mechanisms of chronic viral hepatitis-mediated metabolic dysfunction and the impact of MAFLD on the progression of liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis C, ChronicHumansNon-alcoholic Fatty Liver DiseaseFatty LiverDisease ProgressionMetabolic Diseases

Stichwörter der Autor:innen

chronic viral hepatitiscirrhosishepatic fibrosishepatitis B virus (HBV)hepatitis C virus (HCV)hepatocellular carcinomametabolic dysfunction-associated fatty liver disease (MAFLD)

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Pilgrim Hospital, United Lincolnshire Hospitals NHS Trust, Boston PE21 9QS, UK.
  • Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust, Royal Preston Hospital, Sharoe Green Lane, Preston PR2 9HT, UK.
  • Department of Family Medicine and Polyclinics, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia.
  • University Diabetes Center, King Saud University Medical City, King Saud University, Riyadh 11411, Saudi Arabia.
  • Faculty of Science, Manchester Metropolitan University, Manchester M15 6BH, UK.
  • Faculty of Biology, Medicine & Health, The University of Manchester, Manchester M13 9PL, UK.

ORCID-Profile: Mohammed Alkhalifah, Joseph M Pappachan

Zitieren

APA

Fernandez, C. J., Alkhalifah, M., Afsar, H., & Pappachan, J. M. (2024). Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink. Pathogens, 13(1), 68. https://doi.org/10.3390/pathogens13010068

Vancouver

Fernandez CJ, Alkhalifah M, Afsar H, Pappachan JM. Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink. Pathogens. 2024;13(1):68. doi:10.3390/pathogens13010068

BibTeX
@article{Fernandez2024,
  author = {Fernandez, Cornelius J and Alkhalifah, Mohammed and Afsar, Hafsa and Pappachan, Joseph M},
  title = {Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink},
  journal = {Pathogens},
  year = {2024},
  volume = {13},
  number = {1},
  pages = {68},
  doi = {10.3390/pathogens13010068}
}
Kostenlos starten →